Contractile function and insulin sensitivity are inversely regulated by insulin in primary myoblast human skeletal muscle microtissues
- 1Institute of Biomedical Engineering, University of Toronto
- 2Faculty of Kinesiology and Physical Education, University of Toronto
- 3Department of Biochemistry and Molecular Biology, University of Calgary
Abstract
Background Insulin resistance in skeletal muscle is a hallmark of Type 2 diabetes mellitus (T2D). Three-dimensional skeletal muscle microtissues (hMMTs) offer advantages over two-dimensional myotube cultures, including enhanced physiological relevance and amenability to repeated contractile stimulation. However, standard hMMT differentiation protocols rely on supraphysiological insulin concentrations. This creates a fundamental conundrum, since the very conditions required to generate functional hMMTs are expected to render them insulin-unresponsive, limiting their utility for modeling T2D. Whether hMMTs can be differentiated under more physiological conditions while maintaining myotube formation, contractile strength, and glucose transporter type 4 (GLUT4) expression and function, and whether insulin responsiveness can be restored post-differentiation, remains unknown. Methods We systematically evaluated the effects of nutrient and insulin conditions on myotube morphometry, contractile function, and glucose transporter profiles (GLUT4, GLUT1, insulin receptor β) in human primary myoblast-derived 2D myotubes and hMMTs. We tested whether reducing insulin or glucose to physiological levels during differentiation impacted hMMT contractility. We then evaluated an insulin re-sensitization protocol involving insulin withdrawal to restore insulin responsiveness and assessed its impact on contractile function, glucose uptake, and AKT signaling. Results Insulin supplementation during differentiation was essential for myonuclear accretion in 2D cultures and for contractile hMMT formation, with supraphysiological insulin (≥ 0.86 µM) levels required for maximal hMMT strength. Physiological glucose levels were sufficient to support myotube formation in 2D and 3D settings and even enhanced hMMT contractile force as compared to standard supraphysiological glucose formulations. hMMTs exhibited ~ 12-fold higher GLUT4 levels and a ~ 40-fold increase in GLUT4:GLUT1 ratio compared to 2D myotubes (p < 0.0001 and p = 0.044, respectively), approaching but not matching native adult human muscle. hMMTs differentiated in supraphysiological insulin appeared to display blunted insulin responsiveness. A 4-day insulin withdrawal period was associated with a partial restoration of insulin sensitivity, increasing insulin-stimulated glucose uptake ~ 1.5-fold and activating AKT signaling (N = 2). However, re-sensitization significantly compromised hMMT contractile strength (p < 0.0001) and fatigue resistance (p = 0.015). Conclusion We demonstrate that hMMTs derived from a 19-year-old female primary myoblast cell line require supraphysiological insulin during differentiation to achieve optimal contractile function and physiologically relevant GLUT4:GLUT1 ratios, but this renders them insulin-resistant. Although insulin withdrawal may partially restore insulin responsiveness, it impairs contractile integrity. These findings highlight a critical trade-off that may limit hMMT-based T2D modeling. Development of insulin-free differentiation protocols that preserve both contractile function and insulin sensitivity is important to unlock the potential of hMMTs for studying contraction-mediated therapeutic interventions in T2D.
Related
- Androgen receptor-regulated ZNF419 modulates ferroptosis sensitivity via the ZDHHC20-GPX4 pathway in prostate cancer.
- A Pmk1-Regulated Mst12-Bip1 Network Coordinates Appressorium Function, Effector Deployment, and Invasive Growth by Magnaporthe oryzae
- Image-based assessment of muscle contractile performance in facioscapulohumeral muscular dystrophy: protocol of the MUSCLE+ observational study in the Netherlands
- Residual cohesin function and PARP1 levels determine PARP inhibitor sensitivity in STAG2-deficient cancers
- High-throughput screen identifies a potent MCU activator boosting cardiac contractile bioenergetics
BibTeX
@article{tiper2026contractile,
title = {{Contractile function and insulin sensitivity are inversely regulated by insulin in primary myoblast human skeletal muscle microtissues}},
author = {Yekaterina Tiper and Jiaru Ni and Lucy Xinyu Ma and Cassidy T. Tinline-Goodfellow and Paul Babits and Roman Krawetz and Daniel R. Moore and Penney M. Gilbert},
journal = {BioMedical Engineering OnLine},
year = {2026},
month = jul,
doi = {10.1186/s12938-026-01603-9},
url = {https://doi.org/10.1186/s12938-026-01603-9},
note = {CC BY},
}
RIS
TY - JOUR
TI - Contractile function and insulin sensitivity are inversely regulated by insulin in primary myoblast human skeletal muscle microtissues
AU - Yekaterina Tiper
AU - Jiaru Ni
AU - Lucy Xinyu Ma
AU - Cassidy T. Tinline-Goodfellow
AU - Paul Babits
AU - Roman Krawetz
AU - Daniel R. Moore
AU - Penney M. Gilbert
PY - 2026
DA - 2026/07/01
JO - BioMedical Engineering OnLine
DO - 10.1186/s12938-026-01603-9
UR - https://doi.org/10.1186/s12938-026-01603-9
AB - Background Insulin resistance in skeletal muscle is a hallmark of Type 2 diabetes mellitus (T2D). Three-dimensional skeletal muscle microtissues (hMMTs) offer advantages over two-dimensional myotube cultures, including enhanced physiological relevance and amenability to repeated contractile stimulation. However, standard hMMT differentiation protocols rely on supraphysiological insulin concentrations. This creates a fundamental conundrum, since the very conditions required to generate functional hMMTs are expected to render them insulin-unresponsive, limiting their utility for modeling T2D. Whether hMMTs can be differentiated under more physiological conditions while maintaining myotube formation, contractile strength, and glucose transporter type 4 (GLUT4) expression and function, and whether insulin responsiveness can be restored post-differentiation, remains unknown. Methods We systematically evaluated the effects of nutrient and insulin conditions on myotube morphometry, contractile function, and glucose transporter profiles (GLUT4, GLUT1, insulin receptor β) in human primary myoblast-derived 2D myotubes and hMMTs. We tested whether reducing insulin or glucose to physiological levels during differentiation impacted hMMT contractility. We then evaluated an insulin re-sensitization protocol involving insulin withdrawal to restore insulin responsiveness and assessed its impact on contractile function, glucose uptake, and AKT signaling. Results Insulin supplementation during differentiation was essential for myonuclear accretion in 2D cultures and for contractile hMMT formation, with supraphysiological insulin (≥ 0.86 µM) levels required for maximal hMMT strength. Physiological glucose levels were sufficient to support myotube formation in 2D and 3D settings and even enhanced hMMT contractile force as compared to standard supraphysiological glucose formulations. hMMTs exhibited ~ 12-fold higher GLUT4 levels and a ~ 40-fold increase in GLUT4:GLUT1 ratio compared to 2D myotubes (p < 0.0001 and p = 0.044, respectively), approaching but not matching native adult human muscle. hMMTs differentiated in supraphysiological insulin appeared to display blunted insulin responsiveness. A 4-day insulin withdrawal period was associated with a partial restoration of insulin sensitivity, increasing insulin-stimulated glucose uptake ~ 1.5-fold and activating AKT signaling (N = 2). However, re-sensitization significantly compromised hMMT contractile strength (p < 0.0001) and fatigue resistance (p = 0.015). Conclusion We demonstrate that hMMTs derived from a 19-year-old female primary myoblast cell line require supraphysiological insulin during differentiation to achieve optimal contractile function and physiologically relevant GLUT4:GLUT1 ratios, but this renders them insulin-resistant. Although insulin withdrawal may partially restore insulin responsiveness, it impairs contractile integrity. These findings highlight a critical trade-off that may limit hMMT-based T2D modeling. Development of insulin-free differentiation protocols that preserve both contractile function and insulin sensitivity is important to unlock the potential of hMMTs for studying contraction-mediated therapeutic interventions in T2D.
SN - 1475-925X
ER -